Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis ; volume:41 ; number:10 ; day:21 ; month:8 ; year:2024 ; pages:3934-3950 ; date:10.2024
Advances in therapy ; 41, Heft 10 (21.8.2024), 3934-3950, 10.2024
- Creator
-
Hauber, Brett
Hong, Agnes
Hunsche, Elke
Maculaitis, Martine C.
Collins, Sean P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-024-02955-1
- URN
-
urn:nbn:de:101:1-2411272139454.258127283427
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hauber, Brett
- Hong, Agnes
- Hunsche, Elke
- Maculaitis, Martine C.
- Collins, Sean P.
- SpringerLink (Online service)
Other Objects (12)
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen deprivation modulates the inflammatory response induced by irradiation
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
On augmenting database schemas by latent visual attributes
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen deprivation modulates the inflammatory response induced by irradiation
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
On augmenting database schemas by latent visual attributes
PTP1B regulates lymphocytes responses androgen deprivation
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Androgen deprivation modulates the inflammatory response induced by irradiation
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Androgen deprivation in prostate cancer: benefits of home-based resistance training
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer